Stock screener

PACB

Conviction 48IndustrialsScan · Thu, Jun 25, 2026
PACB$1.60+11.11%
ResistanceSupportVol 14
63 bars
Vol MA14 5.76M
Mar 26Apr 14May 1May 19Jun 8Jun 25
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.LABORATORY ANALYTICAL INSTRUMENTSwww.pacb.com
Price1.60
Change+11.11%
Gap+0.69%
Rel volume2.98×
Avg volume6.39M
Avg $ vol9.37M
SMA 201.43
SMA 501.45
SMA 2001.69
Price vs 50+10.58%
Price vs 200-5.08%
MA stackmixed
50/200 cross
Supertrenddown · 1.64
RSI (14)63
MACD hist0.02
MACD crossbull · 1d
Stoch %K / %D79 / 38
ADX (14)13
+DI / −DI33 / 16
RSI divergence
MACD divergence
ATR %+7.55%
ADR %8.73%
52w high2.67
52w low1.12
From 52w high-40.07%
Above 52w low+42.86%
New 52w highNo
SqueezeOff
Bollinger width29.73%
%B0.89
Donchian pos64.58%
Donchian high1.77
Donchian low1.29
AVWAP (52w high)1.57
vs AVWAP high+1.66%
AVWAP (52w low)1.41
vs AVWAP low+13.73%
OBV trendUp
Chaikin MF (20)-0.02
Today vs 20d2.98×
Avg vol (14d)5.76M
Avg vol (20d)6.39M
Avg $ vol (20d)9.37M
Market cap496.96M
RS 3m (vs SPY)-8.66%
RS 6m (vs SPY)-29.48%
RS line new highNo
Trend template4/8
Technical rank51.6
1 week+19.40%
1 month+26.98%
3 months+15.11%
6 months-12.09%
1 year+33.33%
YTD-13.04%
P/E-0.91
P/B210.04
P/S6.32
P/FCF-4.36
EPS-1.82
Div yield
ROE
ROA-69.84%
Debt/Eq5.72
Current5.65
EV/EBITDA-0.83
Gross margin58.23%
Net margin-694.90%
Rev growth-15.88%
EPS growth-76.34%
Price target2.38
Target upside48.75%
Analyst ratingBuy
Institutional67.74%
Ent. value454.22M
Revenue37.18M
Net income-8.28M
Gross profit12.84M
Free cash flow-113.92M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out
Employees485
ListedWed, Oct 27, 2010
Free float259.69M
Float %86.0%
Short interest48.71M
Days to cover8.6d
Short volume44.5%
Squeeze score80 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.14 · 1 est
Last EPS vs est−$0.12 vs −$0.17
Last surprise+29.4% beat
Setup gradeC
Conviction48 / 100
Pattern quality
Tech rank51.6 / 100
Group rank77 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance1.77
Support1.19
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PACB

All disclosures →
No recent disclosed trades by Congress in PACB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PACB · 10 buys

InsiderSideShares
Ericson William W.
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
LIVINGSTON RANDALL S
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Smith Christopher M
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
MOHR MARSHALL
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Gibson Christopher
Director · Stock Option (right to buy) · 2026-06-03
Grant74.5K
ORDONEZ KATHY
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
MILLIGAN JOHN F
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Valantine Hannah
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Gibson Christopher
Director · Common Stock · 2026-04-08
Grant57.47K
Gibson Christopher
Director · Stock Option (right to buy) · 2026-04-08
Grant77.84K

SEC filings

EDGAR filings in PACB · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.